Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Research by Quarter
Research — Outsourced services and other direct costs ($M) ($M)
Vertex Pharmaceuticals Research: $71.2M in Q2 2026, up 0.3% from a year earlier.
Where the Q2 2026 figure comes from
“|| Outsourced services and other direct expenses | 71.2 | 71.0 | —% | 137.8 | 144.1 | (4)%”
Source: Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K MD&A (Research Expenses Disaggregation Table).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals Research ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rd-res-outsourced
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.